Stay updated on Entinostat + Pembrolizumab in Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:40:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    This update is a minor site revision (Revision: v3.4.2) with removal of an older funding-status notice, and does not modify core trial details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:03:09.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding status notice banner was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T07:35:57.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and a new revision note (Revision: v3.4.0). Minor formatting changes include capitalization tweaks to 'Last Update Submitted that Met QC Criteria' vs 'Last Update Submitted that met QC Criteria' and 'No FEAR Act Data' vs 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:45:35.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 in the page footer. No substantive study information appears to have changed.
    Difference
    0.1%
    Check dated 2026-01-14T03:07:43.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a dedicated 'Locations' section listing study sites in Illinois, New Jersey, and New York. Removed the separate 'Illinois Locations', 'New Jersey Locations', and 'New York Locations' subsections.
    Difference
    0.4%
    Check dated 2025-12-23T17:15:15.000Z thumbnail image

Stay in the know with updates to Entinostat + Pembrolizumab in Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.